Pharmagene

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

ISSN-2321-0966 (Print) ISSN-2321-0974 (Online)

PHARMAGENE
Vol: 1 Issue:2

Research Article

www.genesisjournals.org

Formulation and Evaluation of Microemulsion Based Gel of Itraconazole


Parag Patel* , Mansi A Monpara, S N Mandal, Nikita Patel, Rajesh KS.
Department of Pharmaceutics, Parul Institute of Pharmacy, Li mda, Vadodara, Gujarat.

Abstract:

The aim of the present study was to investigate the potential of a microemulsion formulation for topical delivery of Itraconazole.
Using pseudo-ternary phase diagram microemulsion area was selected and according to that ratio of oil, surfactant and
cosurfactant microemulsion was optimized. The prepared microemulsion was subjected for various tests like size distribution
study, zeta potential, conductance, % transmittance and centrifugation. The optimized microemuls ion was then incorporated in
the 1% carbopol 934 gel in ratio of 1:1. The prepared microoemulsion based gel was subjected to various tests like extrudability,
spreadability, drug content, In-vitro drug release and rheological study and in-vitro antifungal activity against C.albicans.

Key-words: M icroemulsion, Itraconazole, Antifungal activity

Received on 15-05-2013 Modified on 15-06-2013 Accepted on 23-06-2013

INTRODUCTION
Fungal infection is a common infection which affects two- delivery.4 For topical delivery microemulsion is
third of population among the world. 1 M any antifungal incorporated in Carbool 934 gel base to prolong the local
drugs are available for treatment of fungal infection like contact to the skin.
M iconazole, Ketoconazole etc. Itraconazole is orally or
topically active antifungal agent with a broad spectrum of MATERIALS AND METHODS
activity. It is effective against several fungal strains such as
Candida albicans and Candida topicalis, which are Materials: Itraconazole was kindly gifted by Alembic
responsible for topical candidiasis 2. Itraconazole shows pharma, Baroda. Tween 80 was purchased from Chemdyes
very low water solubility and having log P value 6.5 which corporation and Ethanol from Lobachemie. All other
indicate high permeability through membrane and it is chemicals used were of AR grade.
beneficial for topical delivery. Systemic side effects can be
overcome by its topical delivery. For topical delivery semi- Methods: Drug dissolved in the oleic acid. Then add
solid preparations are widely accepted over solid and liquid Tween 80 and Ethanol as surfactant and Co-surfactant
dosage forms 3. M icroemulsions, which are optically respectively. M ixed well all of them. Then water was added
isotropic and thermodynamically stable systems of water, drop by drop and mixed well on magnetic stirrer.
oil, surfactant, and co-surfactant, have been studied as drug Transparent microemulsion was formed. Now for
delivery systems because of their capacity to solubilize preparation of Gel base, Carbopol 934 was suspended in
poorly water-soluble drugs as well as their enhancement of water and hydrated it for overnight. pH was adjusted
topical and systemic availability. It helps to solubilize the around 6 to 6.5 using Triethanolamine. For preparation of
lipophilic drug moiety and it shows rapid and efficient M icroemulsion based gel; M icroemulsion and 1% Carbopol
penetration to the skin. So it is beneficial for topical drug 934 gel were mixed in the ratio of 1:1.
*Address for correspondence:
M r. Parag P atel, S olubility of itraconazole 5
E-mail: p4pharmacy@yahoo.co.in Solubility of itraconazole was determined in various oils
Contact: +919825566115 like castor oil, light liquid paraffin, capmul M CM , oleic

32
Microemulsion Based Gel of Itraconazole

acid,Iso propyl myristate, coconut oil, surfactants like Technai-20 electron microscope (Philips, Holland) with an
tween 60, tween 80, tween 40 and cosurfactants like accelerated voltage of 20 - 200 kV. The samples were
Isobutyl alcohol, ethanol, acconan and Isopropyl alcohol. negatively stained with a 1% aqueous solution of
Excess of Itraconazole was added to 5 ml each, of oils, phosphotungstic acid (PTA). M icroemulsion was dried on a
surfactants, and co-surfactants in screw capped tubes and carbon coated copper grid. After drying, the samples were
shaken on orbital flask shaker at 100 RPM for 48 hours at viewed under microscope 80 kV.
ambient temperature. The suspension was centrifuged at
5000 RPM and clear supernatant liquid was decanted and Characterization of microemulsion based gel
filtered through Whatmann filter paper. The solubility of Physical appearance: The prepared Itraconazole gellified
Itraconazole was estimated by UV-visible microemulsion formulations were inspected for their color,
spectrophotometer. homogeneity, consistency and pH. The pH values of 1%
aqueous solutions of the prepared Gellified microemulsion
Pseudo-ternary phase diagram5 were measured by a pH meter.
The microemulsion region was determined by constructing S preadability measurement7: To determine the
pseudo-ternary phase diagrams which are prepared by spredability of M icroemulsion based gel, 0.5 g of gel was
using CHEM IX software. Water titration method was used placed within a circle of 1 cm diameter pre-marked on a
for its determination. These diagrams help to determine oil, glass plate, over which a second glass plate was placed. A
surfactant and co-surfactant ratio. Different mixtures of weight of 500 g was allowed to rest on the upper glass plate
surfactant to co-surfactants were prepared and the ratios for 5 min. The increase in the diameter due to gel spreading
were fixed to 2:1, 3:1 and 4:1. These mixtures (S/CoS) was noted.
were mixed with oil phase to give weight ratio of 4.5:0.5, Rheological study: The viscosity of M icroemulsion based
4:1, 3.5:1.5, 3:2, 2.5:2.5, 2:3, 1.5:3.5, 1:4 and 0.5:4.5, water gel formulation was determined at 37ºC using a brook field
was added drop by drop and stirred using magnetic stirrer viscometer (Brookfield DV‐E viscometer). ). 62 no spindle
until homogeneous dispersion or solution was obtained. was used and rpm set at 12.
The end point of the titration was the point in which the Drug content determination: Itraconazole content in
solution becomes cloudy or turbid. The quantity of water microemulsion based gel was measured by dissolving
required to make the mixture turbid was noted. known quantity of microemulsion based gel in solvent
(methanol) by Sonication. Absorbance was measured after
Characterization of Microemulsion suitable dilution at 280 nm using UV/VIS
Droplet size measurements: Size analysis of spectrophotometer (UV‐1700 CE, Shimadzu Corporation,
microemulsion was carried out by dynamic light scattering Japan).
with zetasizer (M alvern instruments ltd., M alvern, U.K). Extru dability (Tube Test)8: It is a usual empirical test to
The polydispersity index of the formulation was measure the force required to extrude the material from
determined by the same instrument. tube. The method adopted for evaluating micoemulsion
Zeta potential measurements: Zeta potential for based gel formulation for extrudability is based upon the
microemulsion was determined using zetasizer (M alvern quantity in percentage of gel and gel extruded from
instrument ltd., UK). aluminum collapsible tube on application of weight in
Dilution test: It is confirmatory test of microemulsion to grams required to extrude at least 0.5 cm ribbon of emulgel
know which type of microemulsion was formed. The in 10 seconds. M ore quantity extruded better is
prepared optimized microemulsion was diluted with water extrudability.
(as external phase). In Vitro release study: Franz diffusion cell (with effective
Conductivity measurement6: The measurement of diffusion area 3.14 cm2 and 15.5 ml cell volume) was used
electrical conductivity gives the quantitative idea of the for the drug release studies. M icroemulsion based gel (1 g)
solubilization of water phase in the selected mixture was applied onto the surface of egg membrane evenly. The
containing oil phase, surfactant and cosurfactant. It also egg membrane was clamped between the donor and the
gives the idea about the types of microemulsion. The oil, receptor chamber of diffusion cell. The receptor chamber
surfactant and co surfactant concentration is selected as per was filled with freshly prepared PBS (pH 5.5) solution. The
optimized formulation. Then the water phase was added receptor chamber was stirred by magnetic stirrer. The
drop wise to the mixture of the oil and amphiphiles and samples collected at suitable time interval. Samples were
electrical conductivity of formulated samples was measured analyzed for drug content by UV visible spectrophotometer
using a conductometer at ambient temperature. at 280 nm after appropriate dilutions. The cumulative
amount of drug released across the egg membrane was
Transmission electron microscopy: Oil globules of determined as a function of time.
M icroemulsion were visualized using TEM , Phillips
33
PHARMAGENE Vol: 1, Issue: 2
Microemulsion Based Gel of Itraconazole

Antifungal activity:9 Antifungal activity of formulation Size measurement and Zeta potential: Globule size of
was checked by cup-plate method. A definite volume of the optimized microemulsion was found to be 142.2 nm. PDI is
Candida albicans suspension (inoculum) was poured into a measure of particle homogeneity and it varies from 0.0 to
the sterilized Sabouraud dextrose agar media (cooled at 1.0. If PDI value closer to 0.0 which indicates narrow size
40ºC) and mixed thoroughly. About 20 ml of this distribution of the formulation. PDI of optimized
suspension was poured aseptically in the petri plates and microemulsion was found to be 0.422 which indicates
kept till the solidification. The surface of agar plates was prepared microemulsion is monodisperse which remains
pierced using a sterile cork borer. The prepared wells were stable and will not convert to the macroemulsion. Results
filled with equal volume of itraconazole containing of globule size and PDI are shown in figure 2.
microemulsion, itraconazole containing microemulsion The magnitude of the zeta potential gives an indication of
based gel, microemulsion without itraconazole and. After the potential stability of the colloidal system. If all the
incubation for 18 to 24 hours at 25°C, the fungal growth particles in suspension have a large negative or positive
was observed and the zone of inhibitions were measured zeta potential then they will tend to repel each other and
using antibiotic zone reader. there will be no tendency for the particles to come together.
However, if the particles have low zeta potential values
RES ULT AND DIS CUSS ION then particles coming together and flocculating. The
Excipient selection: All selected oils, surfactants and general dividing line between stable and unstable
cosurfactants followed under GRAS (Generally Regarded suspensions is generally taken at either +30 or -30 mV.
As Safe). Selection of oil based upon solubility of Particles with zeta potentials more positive than +30 mV or
itraconazole in oil. Itraconazole shows better solubility in more negative than -30 mV are normally considered stable.
oleic acid so this oil keeps itraconazole in solubilized form. There will be no force to prevent the zeta potential was
Safety is a major determining factor in choosing a found to be -26.7 which shows good stability of
surfactant, as a large amount of surfactants may cause skin microemulsion. Result of zeta potential is given in figure 3.
irritation. Non-ionic surfactants are less toxic than ionic
surfactants. High HLB value surfactants form stable o/w
microemulsion. So tween 80 was selected as surfactant
which having HLB value 15. M oreover for better stability
of microemulsion secondary stabilizer added called co-
surfactant. It fills gap between surfactant molecule and
provide flexibility to the film. The co-surfactant selected
for the study was ethanol which has an HLB value of 4.2.
The suitable combination of high and low HLB surfactant
and cosurfatant shows better stability of microemulsion.
Carbopol 934 is good gelling agent and shows good gelling
property after hydration. Carbopol 934 form gel at neutral
pH. So to neutralize negative charge of carboxylic acid,
Triethaolamine added.

Pseudo-ternary phase diagram:


Based on solubility study oleic acid selected as oil, tween
80 selected as surfactant and Ethanol selected as co-
surfactant. In pseudo-ternary phase diagram one axis
represent oil phase, other rep resent the aqueous phase and
third represent fixed weight ratio of surfactant and co-
surfactant. Here coloured area in the figure 1 refers to the
microemulsion region while the outside area shows
multiphase turbid regions. From pseudo-ternary phase
diagram of different ratio of Tween 80 & ethanol it was
found that best microemulsion zone was found for ratio 4:1.
So this oil, surfactant and co-surfactant ratio was used in
preparation of microemulsion. These phase diagrams are
given in figure 1.
Figure 1: Pseudo-ternary phase diagrams

34
PHARMAGENE Vol: 1, Issue: 2
Microemulsion Based Gel of Itraconazole

Dilution test: Upon dilution with water no phase


separation was observed. So, it proved that prepared
microemulsion is o/w type.

Conductivity measurement: This is one type of


confirmatory test of microemulsion to know the type of
microemulsion formed. When up to 5% of water added
shows no significant change in the conductivity because oil
concentration is more than water concentration so
resistance is more. When 5% to 45% water added
conductivity increase significantly shows bicontinuous
region of microemulsion but above 45% of water no Figure 5 : In-vitro release profile of Itraconazole
significant change in conductivity. Conductivity remain formulation
constsnt upon further addition of water which shows that
o/w type microemulsion formed. This is shown in figure 4. TEM analysis: TEM image is indicative of globule size of
M E. Figure 20 indicates that oil globules of optimized
microemulsion were spherical in shape and size range in
between 30-50 nm. TEM image of optimized
microemulsion is shown in figure 5.

Physical appearance: The prepared Itraconazole


microemulsion based gel formulation was yellow viscous
clear gel preparation with a smooth and homogeneous
appearance. The pH values of prepared formulation
ranged from 6.5 to 6.8, which are acceptable because adult
human skin pH is 5.5-6.4 so skin irritation can be avoided.

Refractive index: Refractive index of optimized


Figure 2: Size measurement
microemulsion based gel was found to be 1.35, measured
by Abbe’s refractometer which was same as refractive
index of water so it indicated that prepared gel was
isotropic in nature.

S preadability measurement: For topical preparation


spreadability is one of the important parameter.The
spreadability is important for ease of application and better
patient compliance. Prepared M E based gel shows increase
in diameter during spreadability measurement was 6.2 cm
which showed good spreadability of the formulation.

Rheological S tudy: Viscosity of final formulation was


Figure 3: Zeta potential measurement found to be 2.6±0.8 cP which indicates that formulation is
good enough to adhere to the skin so ultimately increase the
local contact for longer time, penetration of drug across the
skin and systemic absorption of drug can be avoided.

Drug Content Determination:Drug content of prepared


microemulsion based gel was found to be 93.34% which
indicates better drug loading capacity of the formulation
and required dose of drug was available for the
pharmacological action.

Extru dability measurement: It is important test for


Figure 4: Conductivity measurement semisolid preparation. Pressure required for extrude the

35
PHARMAGENE Vol: 1, Issue: 2
Microemulsion Based Gel of Itraconazole

more quantity of semisolid preparation is depend on the drug. So it delayed the drug release due to more
viscosity and consistency of the formulation. M ore quantity partitioning between internal and external components.
of microemulsion based gel extrude at little applied
pressure on tube which shows better patient compliance. Antifungal activity: M icroemulsion based gel without
drug shows no zone of inhibition. But microemulsion based
In-Vitro Drug Release Study: In-vitro drug release is gel with itraconazole shows 28.3 mm zone of inhibition and
important tool to predict that how much amount of the drug marketed preparation shows 22.8 mm zone of inhibition.
was available at site of application. Final formulation This showed that prepared microemulsion based gel of
shows 78% of drug release. In M E preparation more itraconazole is better than marketed formulation.
quantity of surfactant used which having low solubility of

Figure 5: TEM image of microemulsion

ACKNOWLEDGEMENTS : 5. Shah R, M agdum C , Wadkar K et al.Fluconazole


Authors are thankful to Alembic Pharma, Vadodara Topical M icroemulsion: Preparation and
(Gujrat, India) for providing free gift sample of Evaluation.Research J. Pharm. and Tech. 2009;2, 353-
itraconazole and also thankful to Parul Institute of 357
Pharmacy, Vadodara for providing all required facilities for 6. Dash M , Chandrasekaran N, M ukherjeeanti A,
completion of research work. “Bacterial activity of sunflower oil microemulsion,
Int. J. Pharm. and Pharm. Sci. 2010 , 2 ,123-128
REFERENCES : 7. Bachhavi Y and Patravalei V .Formulation of
1. Jain A, Jain S and Rawat S.Emerging fungal meloxicam gel for topical application:In vitro and in
infections among children: A review on its clinical vivo evaluation. Acta Pharm. 2010; 60, 153–163
manifestations, diagnosis, and prevention. J of 8. Barakat N, Fouad E and Elmedany A.Formulation
Pharm & Bioallied sci. 2010; 314-320 Design of Indomethacin-Loaded Nanoemulsion For
2. Deveda P, Jain A, Vyas N et al.Gellified emulsion for Transdermal Delivery. Pharm. Analytica Acta.
sustain delivery of Itraconazole for topical fungal 2011;1-8.
diseases.Int. J. of Pharm. and Pharm. Sci. 2010; 104- 9. Sarkar B, Patel R, Bhadoriya U .Antimicrobial
112 Activity of Some Novel Pyrazoline Derivatives. J
3. Sailesh.Topical Drug Delivery Systems: A Advanced Pharm Edu & Res .2011; 243-250
Review”.Pharmaceutical information & blog. 2008
4. Rao Y, Sree K and Chowdary K. M icroemulsions: A
Novel drug carrier system. Int J Drug Delivery Tech.
2009; 2, 39-41

36
PHARMAGENE Vol: 1, Issue: 2

You might also like